The QMN Weekly Bulletin

While counterproductive cross-border repackaging requirements in the EU remain a concern for drug distributors, an industry group said it is now on board with a drugmaker-backed supply chain security plan to scan all medicines at the point of dispensing. The 70-member European Association of Euro Pharmaceutical Companies is committed to helping oversee the supply chain safety plan, Heinz Kobelt, secretary general of the group, said. But member states require drug products to be repackaged when they move from one national market to the next, which would create “difficult trademark situations” and potentially costly legal battles for the drug distributors and drugmakers paying for the harmonized plan.
International Pharmaceutical Regulatory Monitor